76
|
Sorin L, Moulis G, Reutenauer S, Delavigne K, Ollier S, Laurent G, Adoue D, Beyne-Rauzy O. P135 Efficacy of rituximab on peripheral thrombopenia in low risk myelodysplastic syndrome. Leuk Res 2009. [DOI: 10.1016/s0145-2126(09)70216-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
77
|
Hervier B, Couret B, Adoue D, Masseau A, Agard C, Ponge T, Hamidou M. Phénotype clinicobiologique du syndrome des antisynthétases anti-PL12 positif. Rev Med Interne 2008. [DOI: 10.1016/j.revmed.2008.10.045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
78
|
Camara B, Martin-Blondel G, Degano B, Astudillo L, Beyne-Rauzy O, Adoue D. Caractéristiques des patients présentant un auto-anticorps anti-ARNt-synthétase au moment de sa mise en évidence : étude rétrospective de 36 cas. Rev Med Interne 2008. [DOI: 10.1016/j.revmed.2008.10.070] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
79
|
|
80
|
Le Moigne M, Chabrol A, Guerrero F, Beyne-Rauzy O, Adoue D. Syndrome de Willebrand auto-immun satellite d’un adénocarcinome colique : une physiopathologie particulière. Rev Med Interne 2008. [DOI: 10.1016/j.revmed.2008.03.244] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
81
|
Chabrol A, Beyne-Rauzy O, Adoue D. Mastite granulomateuse : problèmes diagnostiques et thérapeutiques. Rev Med Interne 2008. [DOI: 10.1016/j.revmed.2008.03.201] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
82
|
Sailler L, Puissant B, Méliani P, Castex JO, Saivin S, Adoue D, Fournie B, Arlet P, Montastruc JL, Lapeyre-Mestre M, Pourrat J, Blancher A. Blood concentrations of hydroxychloroquine and its desethyl derivative correlate negatively with the percentage of CD45RO+ cells among CD4+ lymphocytes in hydroxychloroquine-treated lupus patients. Ann N Y Acad Sci 2007; 1108:41-50. [PMID: 17893969 DOI: 10.1196/annals.1422.005] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
The objective of the study was to investigate the influence of the blood concentrations of hydroxychloroquine ([HCQ]) and its derivative desethylhydroxychloroquine ([DHCQ]) on lymphocyte activation or differentiation in HCQ-treated lupus patients. We studied the correlations between [HCQ], [DHCQ], and the frequency of various lymphocyte subsets in 58 HCQ-treated lupus patients (mean HCQ dose: 4.93 +/- 1.58 mg/kg/day; mean duration of the disease: 122 +/- 64 months). [HCQ] and [DHCQ] were determined by high-performance liquid chromatography (HPLC). Lymphocyte markers were studied by flow cytometry using monoclonal anti-CD3, -CD4, -CD8, -CD25, -DR, -CD45RA, -CD45RO, -CD19, -CD38, and -CD86 antibodies. sIL2-R serum concentrations were measured by enzyme-linked immunosorbent assay (ELISA). [HCQ] and [DHCQ] were 599.9 ng/mL (median: 529.5; range: 55-1935) and 353.43 (median: 286 ng/mL; range: 118-1090). In a multiple regression analysis, [HCQ] and [DHCQ] were associated with the HCQ prescribed dose in mg/kg/day (P = 0.0002 and P = 0.03) and with compliance to the treatment (P = 0.004 and P = 0.03). We found a negative correlation between [HCQ], [DHCQ], and the CD45RO+ cell frequency among CD3+CD4+ cells (P = 0.03 and P = 0.007, respectively). Other lymphocyte subset markers (LSMs) and sIL2-R concentrations were not significantly associated with [HCQ] or [DHCQ]. In the multiple regression analysis, CD45RO+ expression was negatively influenced by [HCQ] (P = 0.005), and positively influenced by smoking habits (P = 0.005) and age (P = 0.005). Similar results were found in the multivariate model including [DHCQ]. Disease activity and taking more than 10 mg/day of corticosteroids or an immunosuppressive drug did not influence CD45RO+ expression. Lupus patients had less CD3+CD4+CD45RO+ cells than controls (P = 0.03). In lupus patients, HCQ and DHCQ may alter the generation or the blood circulation of CD4+CD45RO+ lymphocytes in a concentration-dependent pattern.
Collapse
|
83
|
Sailler L, Pereira C, Bagheri A, Uro-Coste E, Roussel B, Roussel H, Adoue D, Fournie B, Laroche M, Zabraniecki L, Cintas P, Arlet P, Lapeyre-Mestre M, Montastruc JL, Arlet-Suau E. Increased exposure to statins in patients developing chronic muscle diseases: a 2-year retrospective study. Ann Rheum Dis 2007; 67:614-9. [PMID: 17768174 DOI: 10.1136/ard.2007.075523] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
OBJECTIVE Case reports have suggested that lipid-lowering drugs (LLDs), especially statins, could induce or reveal chronic muscle diseases. We conducted a study to evaluate the association between chronic muscle diseases and prior exposure to LLDs. METHOD This was a retrospective study of chronic primary muscle disease cases newly diagnosed at the Toulouse University Hospitals between January 2003 and December 2004 among patients living in the Midi-Pyrénées area, France. All patients remained symptomatic for more than 1 year after drug withdrawal, or required drugs for inflammatory myopathy. Data on the patient's exposure to LLDs and to other drugs were compared with that of matched controls (5/1) selected through the Midi-Pyrénées Health Insurance System database. RESULTS A total of 37 patients were included in the study. Of those, 21 (56.8%) suffered from dermatomyositis (DM) or polymyositis (PM), 12 (32.4%) from genetic myopathy, and 4 (10.8%) from an unclassified disease. The prevalence of exposure to statins was 40.5% in patients and 20% in controls (odds ratio (OR) 2.73, 95% confidence interval (CI) 1.21-6.14; p<0.01). There was a significant positive interaction between statins and proton pump inhibitors exposure (weighted OR 3.3, 95% CI 1.37-7.54; p = 0.02). Statin exposure rate was 47.6% among patients with DM/PM (OR 3.86, 95% CI 1.30-11.57; p<0.01). There was no difference between patients and controls for exposure to fibrates. CONCLUSION Patients who developed chronic muscle diseases after the age of 50, including DM/PM, had a higher than expected frequency of prior exposure to statins. Further studies are needed to confirm this association and the role of proton pump inhibitors.
Collapse
|
84
|
Cartery C, Giron J, Adoue D, Beyne-Rauzy O. Corrélations tomodensitométrie thoracique–données cliniques et fonctionellelles au cours du syndrome de Gougerot-Sjögren. Rev Med Interne 2007. [DOI: 10.1016/j.revmed.2007.03.272] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
85
|
Sailler L, Meliani P, Castex O, Arlet P, Adoue D, Blancher A, Lapeyre-Mestre M, Montastruc JL, Saivin S, Pourrat J. Intérêt de la mesure des concentrations sanguines d'hydroxychoroquine et de son métabolite le déséthylhydroxychloroquine pour la prédiction des rechutes à un an au cours du lupus systémique. Étude chez 58 patients. Rev Med Interne 2007. [DOI: 10.1016/j.revmed.2007.03.096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
86
|
Adoue D, Rambeloarisoa J, Beynes-Rauzy O, Sarrot-Reynauld F, Roblot P, Sibilia J, Durand JM, Constans J, Quéré I, Damade R, Smaïl A, Farge D. Autogreffe de cellules de cellules souches hématopoïétiques dans la sclérodermie systémique sévère: le protocole européen ASTIS. Rev Med Interne 2006. [DOI: 10.1016/j.revmed.2006.10.023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
87
|
Méliani P, Sailler L, Castex JO, Puissant B, Saivin S, Adoue D, Fournie B, Montastruc JL, Arlet P, Pourrat J, Lapeyre-Mestre M, Blancher A. Les concentrations sanguines d'hydroxychloroquine et de son métabolite desethylhydroxychloroquine sont corrélées négativement avec le pourcentage de lymphocytes CD45RO+ parmi les T-CD4+ chez les patients lupiques. Rev Med Interne 2006. [DOI: 10.1016/j.revmed.2006.10.044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
88
|
Gaudin C, Fortenfant F, Adoue D, Beyne-Rauzy O. Autoanticorps anti-PM-Scl. Étude de prévalence et de signification. Rev Med Interne 2006; 27:665-70. [PMID: 16797795 DOI: 10.1016/j.revmed.2006.05.015] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2006] [Accepted: 05/19/2006] [Indexed: 11/28/2022]
Abstract
OBJECTIVE The purpose of our study is to appreciate the prevalence of antibodies anti PM-Scl within the framework of antinuclear antibodies detection and to clarify clinical biological and evolutive features associated to these antibodies. METHODS 9,747 consecutive antinuclear testing datas allowed us to evaluate anti PM-Scl antibodies frequency. A retrospective analysis of patients characteristics was performed to identify clinical, biological and evolutive signs associated with this antibody over a five years follow up period. RESULTS Over the 9,747 samples tested for antinuclear antibodies detection, 3,493 (35.8%) are positive. An anti ENA activity is observed in 727 (7.5%) cases and anti PM-Scl in 6 (0.06%). These antibodies are described in systemic sclerosis, myositis or overlap syndromes. All theses diseases showed a low evolutivity over the five years of follow up. CONCLUSIONS Low prevalence and possible association with an overlap autoimmune syndrome of quite good prognosis are reported with anti PM-Scl antibodies.
Collapse
|
89
|
Beyne-Rauzy O, Couret B, Fortenfant F, Adoue D. Auto-immunité anti-Ku. Étude de prévalence et de signification clinique. Rev Med Interne 2004; 25:619-22. [PMID: 15363616 DOI: 10.1016/j.revmed.2004.03.015] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2003] [Accepted: 03/31/2004] [Indexed: 10/26/2022]
Abstract
PURPOSE Auto-immunity against Ku nuclear antigens is rare and clinical meaning remains badly estimated. Our study is for purposes: to appreciate the prévalence of antibodies anti-Ku within the framework of the search for antinuclear antibodies and to clarify clinical and biological relations associated to this auto-immunity. METHODS A retrospective study of a series of 10,000 searches for antinuclear antibodies studies the prévalence of the auto-immunity anti-Ku and a retrospective analysis of the data found at the patients bearers of an anti-Ku identifies clinical and biological signs associated with this antibody. RESULTS Prévalence anti-Ku is low (1/3493 case of antinuclear antibodies) and association is possible with in a myositic process through variable auto-immune contexts (overlap syndrome) of relative good preview. CONCLUSION Auto-immunity anti-Ku is so characterized with its weak prévalence, a possible observation during different auto-immune diseases with an obvious frequency of the overlap syndrome often concerning a process myositic. Finally a weak évolutivité seems to characterize the auto-immune diseases of the patients with anti-Ku antibodies.
Collapse
|
90
|
Beyne-Rauzy O, Adoue D. Une boîte aux lettres informatique comme outil de formation médicale continue. Rev Med Interne 2003. [DOI: 10.1016/s0248-8663(03)80352-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
91
|
Arista S, Léger P, Beyne-Rauzy O, Bidegain F, Delobel P, Astudillo L, Gaudin C, Godel A, Arlet-Suau E, Adoue D. Trois cas d'amputation de jambe: complicationmacrovasculaire de la sclérodermie ? Rev Med Interne 2003. [DOI: 10.1016/s0248-8663(03)80451-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
92
|
Léger P, Beyne-Rauzy O, Bidegain F, Arista S, Delobel P, Gaudin C, Godel A, Adoue D. Répartition des lésions macrovasculaires au coursde la sclérodermie : à partir d'une étude cas-témoins prospective de 45 cas. Rev Med Interne 2003. [DOI: 10.1016/s0248-8663(03)80336-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
93
|
Bidegain F, Thébault S, Beyne-Rauzy O, Arista S, Godel A, Gaudin C, Delobel P, Alric L, Adoue D. Comparaison du syndrome de Reynolds et du CRESTsyndrome. À propos de 40 cas. Rev Med Interne 2003. [DOI: 10.1016/s0248-8663(03)80328-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
94
|
Arista S, Castex A, Chauvet E, Adoue D. Granulome annulaire et diabète:Une association discutée. Rev Med Interne 2003. [DOI: 10.1016/s0248-8663(03)80020-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
95
|
Busato F, Castex A, Godel A, Adoue D. Analyse des résultats d'un registredes pathomimies cutanées. Rev Med Interne 2003. [DOI: 10.1016/s0248-8663(03)80024-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
96
|
Mari A, Castex A, Beyne-Rauzy O, Adoue D. Expression cutanée et systémique de l'alcaptonurie. Rev Med Interne 2003. [DOI: 10.1016/s0248-8663(03)80159-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
97
|
Delobel P, Beyne-Rauzy O, Porte L, Adoue D. Pemphigoïde gestationis: Présentation clinique et évolutive. Rev Med Interne 2003. [DOI: 10.1016/s0248-8663(03)80015-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
98
|
Beyne-Raury O, Arista S, Godel A, Fortenfant F, Oksman F, Delobel P, Busato F, Porte L, Blancher A, Adoue D. Dépistage des anticorps antinucléaires par immunofluorescence indirecte sur cellules Hep-2 évaluation du rendement diagnostique et conséquences. À propos de 10 000 demandes. Rev Med Interne 2002. [DOI: 10.1016/s0248-8663(02)80423-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
99
|
Beyne-Rauzy O, Castex A, Adoue D. [Association of ankylosing spondylitis and recurrent Horton's disease]. Rev Med Interne 2002; 23:570-1. [PMID: 12108185 DOI: 10.1016/s0248-8663(02)00616-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
100
|
Bousquet E, Galinier A, Rauzy-Beynes O, Adoue D, Thouvenote J, Albarède J. Le déficit en vitamine C chez le sujet âgé hospitalisé. Rev Med Interne 2002. [DOI: 10.1016/s0248-8663(02)80350-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|